LONDON, England, Sept. 25 -- Hogan Lovells Cadwalader, a law firm, issued the following news release:

* * *

Hogan Lovells Cadwalader advises Anavex Life Sciences on annual meeting victory

24 September 2026

Boston, Denver, New York, Philadelphia - A Hogan Lovells Cadwalader team advised Anavex Life Sciences Corp. (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system dise . . .

Click here for more information about our products